Chronic venous ulcers are often complicated by persistent bacterial colonisation and biofilm formation, impairing healing and limiting definitive surgical closure. We report the compassionate-use treatment of a chronic venous leg ulcer, presumed to be adversely affected by persistent Pseudomonas aeruginosa colonisation using sequential topical administration of two lytic bacteriophages, TIVP-27M and LPS-26. Phage therapy was well tolerated and associated with improvement in clinically suspected biofilm-related indicators. Surgical ulcer coverage was subsequently performed. Longitudinal microbiological and genomic analyses showed persistence of a clonal P. aeruginosa lineage, with transient emergence of a phage-resistant isolate on day 16. This isolate exhibited impaired growth and reduced swimming, swarming, and twitching motility, alongside genomic alterations affecting surface-associated and motility-related functions, including pilR , flgE , galU , and hmgA . Later isolates remained susceptible to both phages. These findings support personalised topical phage therapy as a potential adjunctive strategy for selected chronic wounds while highlighting complex evolutionary dynamics during treatment.
No takes yet. Share an insight, caveat, or question.
Passerini et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: